CME webinar series: Empowering Providers on Substance Use Disorders

Jun. 2025Education/Webinars

Register for our new CME webinar series: Empowering Providers on Substance Use Disorders

Join us for our upcoming CME webinar series, "Empowering Providers," designed to enhance your knowledge and skills in managing substance use disorders. This four-part series will provide you with the latest insights and evidence-based strategies to improve patient outcomes.

Overdose Prevention and Response Training

  • Join us on Aug. 26, 2025, from noon to 1 p.m., to learn how to recognize overdose risks and symptoms, respond effectively, and apply proven strategies to prevent patient overdose.

    Comprehensive Care for Alcohol Use Disorder

  • Join us on Sept. 9, 2025, from noon to 1 p.m., to explore the importance of screening for alcohol use disorder (AUD), learn how to use effective screening tools, and apply evidence-based treatment strategies to improve patient care.

    Comprehensive Care for Opioid Use Disorder

  • Join us on Sept. 30, 2025, from noon to 1 p.m., to explore the importance of screening for opioid use disorder (OUD), learn how to use effective screening tools, and implement evidence-based treatments to support recovery.

    Comprehensive Care for Tobacco Use Disorder

  • Join us on Nov. 12, 2025, from noon to 1 p.m., to learn how to recognize tobacco use disorder (TUD), use proven screening tools, and deliver evidence-based care to help patients quit tobacco successfully.

Register Now

Provider is responsible for verifying CME eligibility.

This activity is approved for the following credit: AMA PRA Category 1 Credit™, ANCC, ACPE, and ASWB. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Recent Announcements

February 2026 UPMC for You and UPMC Community HealthChoices formulary update

Pulmicort Flexhaler has a new distributor, Rubicon Holding. National Drug Codes (NDCs) for Pulmicort Flexhaler from Rubicon Holding are not included in the Medicaid Drug Rebate program and are not covered under the Medicaid Prescription Drug Program. Pulmicort Flexhaler NDCs from the previous manufacturer, H2 Pharma, have been discontinued but may be billed/dispensed until supplies are exhausted.
Feb. 2026Pharmacy Updates

CME Webinar: American Foundation for Suicide Prevention’s ‘Talk Saves Lives’ Program

Please join us on Tuesday, April 28, from noon to 1 p.m. for “Talk Saves Lives: An Introduction to Suicide Prevention.” This live, CME-accredited webinar is the American Foundation for Suicide Prevention’s flagship suicide prevention education program. It covers the scope of this leading cause of death, warning signs and risk factors for suicide, and strategies to prevent it.
Feb. 2026Education/Webinars

Training Webinar: Conversio Health COPD Management Program

Please join us for a live training webinar by UPMC Health Plan that will provide an overview of a comprehensive COPD management program from Conversio Health.
Jan. 2026Education/Webinars